Document ID: FDA-2010-N-0001-0065
Agency: fda
Document Type: Notice
Title: Meetings: Tobacco Product Constituents Subcommittee of the Tobacco Products Scientific Advisory Committee
Posted Date: 2010-06-15T04:00Z

[Federal Register: June 15, 2010 (Volume 75, Number 114)]
[Notices]               
[Page 33814-33815]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr15jn10-86]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-N-0001]

 
Tobacco Product Constituents Subcommittee of the Tobacco Products 
Scientific Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Tobacco Product Constituents Subcommittee of the 
Tobacco Products Scientific Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on July 7, 2010, from 8:30 
a.m. to 5 p.m. and on July 8, 2010, from 8 a.m. to 5 p.m.
    Location: Hilton Washington DC North/Gaithersburg, Montgomery 
Ballroom, 620 Perry Pkwy., Gaithersburg, MD 20877. The hotel phone 
number is 301-977-8900.
    Contact Person: Karen Templeton-Somers, Office of Science, Center 
for Tobacco Products, Food and Drug Administration, 9200 Corporate 
Blvd., Rockville, MD 20850, 1-877-287-1373 (choose Option 4), e-mail: 
TPSAC@fda.hhs.gov or FDA Advisory Committee Information Line, 1-800-
741-8138 (301-443-0572 in the Washington, DC area), code 8732110002. 
Please call the Information Line for up-to-date information on this 
meeting. A notice in the Federal Register about last minute 
modifications that impact a previously announced advisory committee 
meeting cannot always be published quickly enough to provide timely 
notice. Therefore, you should always check the agency's Web site and 
call the appropriate advisory committee hot line/phone line to learn 
about possible modifications before coming to the meeting.
    Agenda: On July 7 and 8, 2010, the subcommittee will continue 
discussions, as needed, from the June 8 and 9, 2010, meeting of this 
subcommittee. The subcommittee will then receive presentations and 
discuss the analytic methods and ancillary and normalization standards 
applicable to the measurement and reporting of harmful or potentially 
harmful constituents in tobacco products, including smoke constituents. 
The subcommittee will finalize its proposed list of harmful or 
potentially harmful constituents, the rational for inclusion of each 
substance, validated methods for measuring the constituents and the 
ancillary and normalization standards for the identified constituents 
for presentation at a future meeting of the Tobacco Products Scientific 
Advisory Committee.
    FDA intends to make background material available to the public no 
later than 2 business days before the meeting. If FDA is unable to post 
the background material on its Web site prior to the meeting, the 
background material will be made publicly available at the location of 
the advisory committee meeting, and the background material will be 
posted on FDA's Web site after the meeting. Background material is 
available at http://www.fda.gov/AdvisoryCommittees/Calendar/
default.htm. Scroll down to the appropriate advisory committee link.

[[Page 33815]]

    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person on or before June 
29, 2010. Oral presentations from the public will be scheduled between 
approximately 2:45 p.m. and 3:45 p.m. on July 7, 2010. Those desiring 
to make formal oral presentations should notify the contact person and 
submit a brief statement of the general nature of the evidence or 
arguments they wish to present, the names and addresses of proposed 
participants, and an indication of the approximate time requested to 
make their presentation on or before June 21, 2010. Time allotted for 
each presentation may be limited. If the number of registrants 
requesting to speak is greater than can be reasonably accommodated 
during the scheduled open public hearing session, FDA may conduct a 
lottery to determine the speakers for the scheduled open public hearing 
session. The contact person will notify interested persons regarding 
their request to speak by June 22, 2010.
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to electrical 
outlets.
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Karen Templeton-
Somers at least 7 days in advance of the meeting.
    FDA is committed to the orderly conduct of its advisory committee 
meetings. Please visit our Web site at http://www.fda.gov/
AdvisoryCommittees/AboutAdvisoryCommittees/ucm111462.htm for procedures 
on public conduct during advisory committee meetings.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: June 10, 2010.
Jill Hartzler Warner,
Acting Associate Commissioner for Special Medical Programs.
[FR Doc. 2010-14383 Filed 6-10-10; 4:15 pm]
BILLING CODE 4160-01-S